Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Tg Therapeutics (TGTX) Interest & Investment Income: 2016-2019

Historic Interest & Investment Income for Tg Therapeutics (TGTX) over the last 3 years, with Jun 2019 value amounting to $1.1 million.

  • Tg Therapeutics' Interest & Investment Income rose 382.96% to $1.1 million in Q2 2019 from the same period last year, while for Jun 2019 it was $1.8 million, marking a year-over-year increase of 208.64%. This contributed to the annual value of $857,000 for FY2018, which is 190.51% up from last year.
  • According to the latest figures from Q2 2019, Tg Therapeutics' Interest & Investment Income is $1.1 million, which was up 622.82% from $149,000 recorded in Q1 2019.
  • Over the past 5 years, Tg Therapeutics' Interest & Investment Income peaked at $1.1 million during Q2 2019, and registered a low of $45,000 during Q2 2017.
  • For the 3-year period, Tg Therapeutics' Interest & Investment Income averaged around $262,444, with its median value being $149,000 (2019).
  • As far as peak fluctuations go, Tg Therapeutics' Interest & Investment Income crashed by 51.42% in 2017, and later skyrocketed by 395.56% in 2018.
  • Over the past 4 years, Tg Therapeutics' Interest & Investment Income (Quarterly) stood at $57,544 in 2016, then soared by 110.27% to $121,000 in 2017, then skyrocketed by 119.83% to $266,000 in 2018, then skyrocketed by 382.96% to $1.1 million in 2019.
  • Its last three reported values are $1.1 million in Q2 2019, $149,000 for Q1 2019, and $266,000 during Q4 2018.